Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20171
20192
20204
20212
20222
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Terminated4
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH2
Novartis Pharmaceuticals2
Alumis Inc1
Amgen1
Beeline Medicines Corporation1
Bristol-Myers Squibb1
GlaxoSmithKline1
Imcyse SA1
Institut de Recherches Internationales Servier1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases16
Immune System Diseases7
Sjogren's Syndrome4
Connective Tissue Diseases3
Lupus Erythematosus, Systemic3
Arthritis2
Arthritis, Rheumatoid2
Diabetes Mellitus, Type 12
Dry Eye Syndromes2
Glomerulonephritis2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.